Early behavioral signs of schizophrenia may include: Withdrawal from friends and family Drop in school or work performance Sleep problems Lack of motivation Decline in personal hygiene Either ...
Ottawa Citizen on MSN1d
Study finds 'concerning link' between hospital visits for psychedelic use and schizophreniaThe research, led by Dr. Daniel Myran, a Canada Research Chair in Social Accountability at the University of Ottawa, followed ...
AbbVie reports disappointing mid-stage data for its schizophrenia drug. Jason Snipe of Odyssey Capital still likes AbbVie ...
Since then, our work, as well as that of other teams, has shown that social cognition impairments mediate the relationship ...
US pharma group says patients who took Emraclidine in clinical trials failed to show a significant decline in symptoms ...
AbbVie said on Monday that an experimental schizophrenia drug it gained through an $8.7 billion deal for Cerevel Therapeutics failed two mid-stage studies, sending the drugmaker's shares plunging 12.5 ...
New research highlights neuroglia (or glia cells) as critical players in mental health, potentially influencing conditions like depression and schizophrenia.
Researchers have developed a potential diagnostic tool for schizophrenia by observing how patients process conflicting information.
Abstracts and additional details can be found at the CNS Summit 2024 website.
When you buy through links on our articles, Future and its syndication partners may earn a commission.
Intra-Cellular Therapies said on Tuesday its drug to prevent relapses in schizophrenia patients met the main goal of a late-stage trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback